Haematologica (Dec 2015)
Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival
- Henk M. Lokhorst,
- Bronno van der Holt,
- Jan J. Cornelissen,
- Marie José Kersten,
- Marinus van Oers,
- Reinier Raymakers,
- Monique C. Minnema,
- Sonja Zweegman,
- Gerard Bos,
- Nicolaas Schaap,
- Shulamiet Wittebol,
- Okke de Weerdt,
- Rianne Ammerlaan,
- Pieter Sonneveld
Affiliations
- Henk M. Lokhorst
- Department of Hematology, VU University Medical Center Amsterdam, The Netherlands
- Bronno van der Holt
- HOVON Data Center, Erasmus MC Cancer Center – Clinical Trial Center, Rotterdam, The Netherlands
- Jan J. Cornelissen
- Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
- Marie José Kersten
- Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands
- Marinus van Oers
- Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands
- Reinier Raymakers
- Department of Hematology, University Medical Center Utrecht, The Netherlands
- Monique C. Minnema
- Department of Hematology, University Medical Center Utrecht, The Netherlands
- Sonja Zweegman
- Department of Hematology, VU University Medical Center Amsterdam, The Netherlands
- Gerard Bos
- Department of Hematology, Academic Hospital Maastricht, The Netherlands
- Nicolaas Schaap
- Radboud University Nijmegen Hospital, Nijmegen, The Netherlands
- Shulamiet Wittebol
- Meander Medical Center, Amersfoort, The Netherlands
- Okke de Weerdt
- Antonius Hospital, Nieuwegein, The Netherlands
- Rianne Ammerlaan
- HOVON Data Center, Erasmus MC Cancer Center – Clinical Trial Center, Rotterdam, The Netherlands
- Pieter Sonneveld
- Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands
- DOI
- https://doi.org/10.3324/haematol.2015.128728
- Journal volume & issue
-
Vol. 100,
no. 12
Abstract
No abstracts available.
